Consultative Sales Using Medical Information and Private-Label Expansion

「By combining various solution tools based on "ASOURCE® DATABASE", a medical supplies database independently developed by the Group and described as one of the largest in Japan, including a logistics management system, the operating-room management support program "SURGELANE®", and the materials price optimization support system "meccul®"」

「Gross profit increased as a result of revenue improvements accompanying stronger sales activities and higher revenue, despite an increase in cost of sales due to the impact of the situation in Ukraine and the weaker yen.」

「By further promoting various solutions businesses, including "SURGELANE®" and "MORISS®", the company will support the efficient operation of medical institutions, contribute to resolving challenges in regional healthcare, and enhance the Group's social value.」

「Against this backdrop, the Group has conducted its business activities based on a policy of maintaining medical systems at healthcare institutions by working to prevent the spread of infection across the Group while ensuring a stable supply of products and addressing customer issues.」

「The Group is expanding and strengthening its operations in the Tokai, Tokyo metropolitan, northern Kanto, Hokuriku and Tohoku areas, based on a basic policy of further promoting medical supplies sales by expanding services for medical institutions, including the operating-room management support program "SURGELANE®" and the medical supplies database and analysis service "meccul®", as well as expanding its business scale through M&A.」

「In the medical equipment distribution industry, the impact of falling medical supplies selling prices due to revisions to medical reimbursement rates is intensifying, while the industry is in a situation where the provision of integrated services that can contribute to improved management and efficiency at medical institutions is required.」

「As selling prices remain on a downward trend, the company will work to secure profits by continuously negotiating selling and purchase prices, strengthening its purchasing power by capitalizing on economies of scale, improving its logistics structure, establishing appropriate inventory management systems, and promoting sales of private-label products. It will also further promote various solutions businesses, including "SURGELANE" and "MORISS".」

「The industry is in a situation where the provision of integrated services that can contribute to improved management and efficiency at medical institutions is required.」

「To address the increasingly diverse needs of healthcare providers, the Group will pursue initiatives that contribute further to regional healthcare, including strengthening its proposal capabilities by promoting its solutions business and improving logistics efficiency by capitalizing on economies of scale, while working to further enhance corporate value.」

「The industry is in a situation where the provision of integrated services that can contribute to improved management and efficiency at medical institutions is required.」

「In the medical equipment distribution industry in which the Group operates, competition among companies is intensifying, including industry consolidation through M&A and business alliances, and the industry is now in a situation where the provision of integrated services that can contribute to improved management and efficiency at medical institutions is required.」

「In the medical equipment distribution industry in which the Group operates, competition among companies is intensifying, including industry consolidation through M&A and business alliances, and the industry is now in a situation where the provision of integrated services that can contribute to improved management and efficiency at medical institutions is required.」

「To address the increasingly diverse needs of healthcare providers, the Group will pursue initiatives that contribute further to regional healthcare, including strengthening its proposal capabilities by promoting its solutions business and improving logistics efficiency by capitalizing on economies of scale, while working to further enhance corporate value.」

「The company worked to promote integrated services that help improve the management of medical institutions, including proposals for "SURGELane®", operating-room support software, "meccul®", a medical supplies database and medical supplies analysis service, and "MORISS", an operating-room information management system designed to manage surgical supplies, through the sale of medical supplies (consumables).」

「The company worked to promote integrated services that help improve the management of medical institutions, including proposals for "SURGELane®", operating-room support software, "meccul®", a medical supplies database and medical supplies analysis service, and "MORISS", an operating-room information management system designed to manage surgical supplies, through the sale of medical supplies (consumables).」

「The company worked to promote integrated services that help improve the management of medical institutions, including proposals for "SURGELane®", operating-room support software, "meccul®", a medical supplies database and medical supplies analysis service, and "MORISS", an operating-room information management system designed to manage surgical supplies, through the sale of medical supplies (consumables).」

「The company is continuing to pursue initiatives that contribute further to regional healthcare, including further strengthening proposal-based sales using hospital management improvement tools such as "SURGELane®" and "meccul®", and improving logistics efficiency by capitalizing on economies of scale.」

「To address these issues, the Group views changes in the healthcare industry as an opportunity and seeks to improve margins through activities that emphasize sales efficiency and further improvements in the working environment. At the same time, it will continue to expand its scale, strengthen consultative sales of high-value-added products through the provision of the latest medical information, and develop private-label products, with the aim of becoming a leading company in the industry.」